| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.021 | 0.6 |